Baidu
map

NEJM:口服抗生素治疗稳定期心内膜炎

2019-02-01 zhangfan MedSci原创

研究认为,对于病情稳定的左心感染性心内膜炎患者可以采用口服抗生素疗法代替静脉注射

左心感染性心内膜炎患者通常需接受6周的静脉抗生素治疗。近日研究人员考察了病情稳定患者,从静脉抗生素转为口服抗生素是否会产生类似于持续静脉治疗的疗效和安全性

400名健康状况稳定的因链球菌、粪肠球菌、金黄色葡萄球菌或凝固酶阴性葡萄球菌引起的心脏心内膜炎患者,随机接受静脉抗生素(199例)或口服抗生素(201例)后继治疗。抗生素注射治疗至少持续10天,口服组如果达到指标即可出院。研究的主要终点为原因死亡率、计划外心脏手术、栓塞事件、复发性菌血症或主要病原体心内感染

静脉抗生素组平均治疗周期19天,而口服组平均治疗周期17天。静脉抗生素组24人(12.1%)以及口服组18人(9.0%)发生主要终点事件(组间差异3.1%),达到非劣性终点。

研究认为,对于病情稳定的左心感染性心内膜炎患者可以采用口服抗生素疗法代替静脉注射。

原始出处:

Kasper Iversen et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.N Engl J Med, January 31, 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1708505, encodeId=d1771e0850548, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Fri Jan 17 11:34:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345237, encodeId=b060134523e63, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350721, encodeId=beda1350e21ba, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417320, encodeId=4ccf141e32082, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359813, encodeId=b44e3598133b, content=学习了,长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Feb 02 12:43:20 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1708505, encodeId=d1771e0850548, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Fri Jan 17 11:34:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345237, encodeId=b060134523e63, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350721, encodeId=beda1350e21ba, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417320, encodeId=4ccf141e32082, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359813, encodeId=b44e3598133b, content=学习了,长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Feb 02 12:43:20 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1708505, encodeId=d1771e0850548, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Fri Jan 17 11:34:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345237, encodeId=b060134523e63, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350721, encodeId=beda1350e21ba, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417320, encodeId=4ccf141e32082, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359813, encodeId=b44e3598133b, content=学习了,长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Feb 02 12:43:20 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1708505, encodeId=d1771e0850548, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Fri Jan 17 11:34:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345237, encodeId=b060134523e63, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350721, encodeId=beda1350e21ba, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417320, encodeId=4ccf141e32082, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359813, encodeId=b44e3598133b, content=学习了,长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Feb 02 12:43:20 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1708505, encodeId=d1771e0850548, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Fri Jan 17 11:34:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345237, encodeId=b060134523e63, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350721, encodeId=beda1350e21ba, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417320, encodeId=4ccf141e32082, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Sun Feb 03 00:34:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359813, encodeId=b44e3598133b, content=学习了,长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Feb 02 12:43:20 CST 2019, time=2019-02-02, status=1, ipAttribution=)]
    2019-02-02 1ddf0692m34(暂无匿称)

    学习了,长知识

    0

相关资讯

Diabetic Med:前驱糖尿病和糖尿病都是感染性心内膜炎不良后果的危险因素?

糖尿病是感染性心内膜炎的危险因素。然而,很少有研究关注前驱糖尿病在感染性心内膜炎中的预后价值。该分析旨在探讨前驱糖尿病与感染性心内膜炎患者预后之间的关系。近日,国际杂志 《Diabetic Med》上在线发表一项关于前驱糖尿病和糖尿病都是感染性心内膜炎不良后果的危险因素的研究。 糖尿病和前驱糖尿病定义基于美国糖尿病协会2014年标准。2009年1月至2015年7月期间共有866名被连续诊断

Circulation:牙科治疗后担心心内膜炎 杞人忧天?

感染性心内膜炎是由菌血症引起的一种致命性并发症。侵入性牙科治疗(IDT)如拔牙等,可致菌血症,因此被认为是感染性心内膜炎(IE)的潜在风险因素。

NEJM:注射联合口服抗生素治疗心内膜炎

研究认为,对于病情稳定的左心感染性心内膜炎患者可以采用口服抗生素疗法代替静脉注射

JACC:经导管肺动脉瓣置换术后的心内膜炎

心内膜炎已逐渐成为先天性右室流出道疾病和假体瓣膜疾病的主要不良并发症之一。本研究的目的旨在评估肺动脉瓣置换术后心内膜炎的发生率和潜在危险因素。本研究纳入分析了309例接受经导管肺动脉瓣置换术(TPVR)的患者,经过平均5.1年时间的随访,有46例患者被诊断为心内膜炎,有35例患者报道有肺动脉瓣置换相关性心内膜炎,心内膜炎的年度化发病率为3.1%每人年,而肺动脉瓣置换相关性心内膜炎为2.4%每人年。

NEJM:TAVR后念珠菌性心内膜炎-病例报道

经食道超声心动图(如图A所示)证实为人工瓣膜心内膜炎,其显示大量赘生物导致人工瓣膜严重受阻(跨瓣平均压力梯度为52 mmHg;主动脉瓣面积为0.5cm2)。

离奇!表现为心内膜炎和肝炎 却找不到病原菌

41岁男性,因劳累后出现间断性低热乏力前往医院就诊。百思不得其解的是,有心内膜炎症和肝脏损害的表现,但始终找不到病原学证据。最终,辗转多家医院,历时2年,才找到病因。

Baidu
map
Baidu
map
Baidu
map